A November 2009 study published in the Archives of Internal Medicine has found that a number of side effects linked to the Ortho Evra patch are among the most commonly missed or delayed diagnoses by physicians. A survey of more than 300 physicians found that cases of pulmonary embolism and stroke frequently resulted in diagnostic errors due to mistakes in assessing patients or other factors. (more…)

A new study published in the Archives of Internal Medicine has found that a number of conditions linked to the use of the Ortho Evra patch are commonly overlooked by physicians. A survey of more than 300 physicians found that pulmonary embolisms and strokes were frequently misdiagnosed due to mistakes in assessing patients or other factors. (more…)

The Food and Drug Administration has approved new labeling changes to the Ortho Evra birth control patch intended to warn users about an increased risk of blood clots and other side effects. According to the new warning, women who use the Ortho Evra patch may be more than twice as likely to suffer serious blood clots as women who are using birth control pills. (more…)

The Ortho Evra patch is still on the market more than one year after a leading consumer advocacy group called on the Food and Drug Administration to issue a recall for the birth control patch. The Public Citizen Health Research Group petitioned the FDA in May 2008 to issue an Ortho Evra recall, citing the increased risk of blood clots and other side effects that that could face women who are use the patch. (more…)

More than one year after the consumer advocacy group Public Citizen called on the Food and Drug Administration to issue a recall of the Ortho Evra birth control patch, the agency has yet to take any publicized action in response. Many women continue to use Ortho Evra—including about 2.7 million prescriptions as recently as 2007—despite the group’s call to withdraw the patch. (more…)